匹利诺生结构式
|
常用名 | 匹利诺生 | 英文名 | IB-MECA |
|---|---|---|---|---|
| CAS号 | 152918-18-8 | 分子量 | 510.286 | |
| 密度 | 2.0±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C18H19IN6O4 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A |
匹利诺生用途IB-MECA是一种腺苷A 3受体激动剂, EC50值为0.11 μM。 |
| 中文名 | 1-Deoxy-1-[6-[((3-Iodophenyl)methyl)amino]-9H-purin-9-yl]-N-methyl-β-D-ribofuranuronamide |
|---|---|
| 英文名 | (2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyloxolane-2-carboxamide |
| 中文别名 | 匹利诺生 |
| 英文别名 | 更多 |
| 描述 | Piclidenoson (IB-MECA) 是一种腺苷A 3受体激动剂, EC50值为0.11 μM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 2.0±0.1 g/cm3 |
|---|---|
| 分子式 | C18H19IN6O4 |
| 分子量 | 510.286 |
| 精确质量 | 510.051239 |
| PSA | 134.42000 |
| LogP | 2.08 |
| 折射率 | 1.808 |
| 储存条件 | 2-8°C，避光干燥密封 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| 海关编码 | 2934999090 |
|
~%
匹利诺生 152918-18-8 |
| 文献：Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646 |
|
~%
匹利诺生 152918-18-8 |
| 文献：Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646 |
|
~%
匹利诺生 152918-18-8 |
| 文献：Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646 |
|
~%
匹利诺生 152918-18-8 |
| 文献：Journal of Heterocyclic Chemistry, , vol. 37, # 2 p. 339 - 341 |
|
~%
匹利诺生 152918-18-8 |
| 文献：Journal of Heterocyclic Chemistry, , vol. 37, # 2 p. 339 - 341 |
|
~%
匹利诺生 152918-18-8 |
| 文献：Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646 |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Equilibrium and kinetic selectivity profiling on the human adenosine receptors.
Biochem. Pharmacol. 105 , 34-41, (2016) Classical evaluation of target selectivity is usually undertaken by measuring the binding affinity of lead compounds against a number of potential targets under equilibrium conditions, without conside... |
|
|
Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
J. Thorac. Cardiovasc. Surg. 140(2) , 440-6, (2010) Adenosine and the activation of specific adenosine receptors are implicated in the attenuation of inflammation and organ ischemia-reperfusion injury. We hypothesized that activation of A(1), A(2A), or... |
|
|
Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine.
Am. J. Physiol. Gastrointest. Liver Physiol. 297(6) , G1147-62, (2009) We tested the novel hypothesis that endogenous adenosine (eADO) activates low-affinity A3 receptors in a model of neurogenic diarrhea in the guinea pig colon. Dimaprit activation of H2 receptors was u... |
| UNII-30679UMI0N |
| Piclidenoson |
| (2S,3S,4R,5R)-3,4-Dihydroxy-5-{6-[(3-iodobenzyl)amino]-9H-purin-9-yl}-N-methyltetrahydro-2-furancarboxamide |
| IBMECA |
| (2S,3S,4R,5R)-3,4-Dihydroxy-5-{6-[(3-iodobenzyl)amino]-9H-purin-9-yl}-N-methyltetrahydrofuran-2-carboxamide (non-preferred name) |
| CF 101 |
| 3-IB-Meca |
| IB-MECA |
| CF101 |
查看所有供应商和价格请点击：
![(3aS,4S,6R,6aR)-6-{6-[(3-Iodobenzyl)amino]-9H-purin-9-yl}-N,2,2-trimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxamide结构式](https://www.chemsrc.com/caspic/214/152918-48-4.png)
CAS号163042-96-4